B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both in vitro and in vivo

被引：0
作者：
Qian Zhang
Zhiqiang Zhang
Guodi Liu
Dehua Li
Zhangjie Gu
Linsong Zhang
Yingjiao Pan
Xingbing Cui
Lu Wang
Guoping Liu
Xiaoli Tian
Ziming Zhang
机构：
[1] Shanghai Yihao Biological Technology Co.,Department of Pediatric Orthopedics
[2] Ltd,Department of General Surgery
[3] National Children’s Medical Center & Children’s Hospital of Fudan University,Department of Orthopaedics
[4] State Key Laboratory of Bioreactor Engineering,undefined
[5] East China University of Science and Technology,undefined
[6] Changhai Hospital,undefined
[7] Shanghai Beautiful Life Medical Technology Co.,undefined
[8] Ltd.,undefined
[9] Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine,undefined
[10] Shanghai Children’s Hospital,undefined
[11] School of Medicine,undefined
[12] Shanghai Jiao Tong University,undefined
来源：
BMC Cancer | / 22卷
关键词：
Osteosarcoma; B7-H3; Chimeric antigen receptor T; Patient-derived xenografts;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 241 条
[1]  
Dhammi IK(2014)Osteosarcoma: a journey from amputation to limb salvage Indian J Orthop 48 233-234
[2]  
Kumar S(2010)Psychosocial and functional outcomes in long-term survivors of osteosarcoma: a comparison of limb-salvage surgery and amputation Pediatr Blood Cancer 54 990-999
[3]  
Robert RS(2014)Osteosarcoma Cancer Treat Res 162 65-92
[4]  
Ottaviani G(2018)Osteosarcoma: accelerating progress makes for a hopeful future Front Oncol 8 4-308
[5]  
Huh WW(2020)Challenges and prospects of chimeric antigen receptor T-cell therapy for metastatic prostate cancer Eur Urol 77 299-2554
[6]  
Palla S(2017)Chimeric antigen receptor T Cells in refractory B-Cell lymphomas N Engl J Med 377 2545-2629
[7]  
Jaffe N(2018)Chimeric antigen receptor-modified T cells: CD19 and the road beyond Blood 131 2621-152
[8]  
Moore DD(2017)CAR T Cell Therapy for solid tumors Annu Rev Med 68 139-217
[9]  
Luu HH(2012)Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma Cancer Gene Ther 19 212-1787
[10]  
Saraf AJ(2009)Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression Mol Ther 17 1779-687
12345678910